Proposition 65, the Safe Drinking Water and Toxic Enforcement Act of 1986 (applicable to all products sold or distributed in California) exists to protect Californian citizens and the State’s drinking water sources from chemicals known to cause cancer, birth defects or other reproductive harm, and to inform citizens about exposure to such chemicals.
Following a 60 day period for public comment which commenced on July this year, 39 chemicals will be discussed at a Carcinogen Identification Committee (CIC) meeting to be held on 12/13 October 2011.
The CIC, the state’s qualified experts on carcinogenicity for Proposition 65, will provide the Office of Environmental Health Hazard Assessment (OEHHA) with advice on the prioritization of these 39 chemicals for possible preparation of hazard identification materials.
OEHHA is the lead agency for the implementation of Proposition 65 and has screened several hundred chemicals in the OEHHA tracking database for evidence of cancer hazard as well as potential human exposure in California.
The 39 chemicals are:
- Abacavir and Its Salts
- Acetaminophen and Appendix A
- Bisphenol A
- Butyl Benzyl Phthalate
- Butylated Hydroxytoluene
- C.I. Disperse Yellow 3
- Chloroalkyl Ethers
- Chloropicrin
- Clodinafop-Propargyl
- Coumarin
- Dapsone
- Dibenzanthracenes and Dibenz[a,c]anthracene
- 3,3′-Dichlorobenzidine-Based Compounds Metabolized to 3,3′-Dichlorobenzidine
- 2,4-Dichlorophenoxyacetic acid (2,4-D) and Its Salts and Esters
- Dicloran
- Dinitroaniline Pesticides and Prodiamine and Trifluralin
- Entecavir
- Flonicamid
- Fluazinam
- Hexythiazox
- Hydralazine and Its Salts
- Isophosphamide
- Metofluthrin
- Mixtures Containing Pentabromochlorocyclohexane
- N-Methyl-N-Nitroso-1-Alkylamines and N-Methyl-N-Nitroso-1-Octanamine, N-Methyl-N-Nitroso-1-Decanamine, N-Methyl-N-Nitroso-1-Dodecanamine, and N-Methyl-N-Nitroso-1-Tetradecanamine
- N-Nitroso-N-Methylaniline
- N-Methylpyrrolidone
- 6-Nitrobenzimidazole
- Pentachloronitrobenzene
- Pimecrolimus and Tacrolimus
- Pivalolactone
- Pyraflufen Ethyl
- Raloxifen and Its Salts
- Stavudine
- Thiophanate Methyl
- Topoisomerase II Inhibitors
- Triazole Antifugal Agents
- 2,4,6-Trimethylaniline and Its Salts
- Tris(2-Ethylhexyl) Phosphate
The deadline for comments and any supporting documentation is 5:00 p.m. on Tuesday, September 20, 2011 – contact coshita@oehha.ca.gov.
Click here for details of the screening procedure
http://www.oehha.ca.gov/prop65/CRNR_notices/state_listing/pdf/finalPriordoc.pdf
Download the document Prioritization: Chemicals Identified for Consultation with the Carcinogen Identification Committee here
BLC members receive a 30% discount on testing.
If you are selling product into California and would like further interpretation of Proposition 65, Proposition 65 testing, the settlements or ensuring compliance within your supply chain contact info@blcleathertech.com or +44 (0) 1604 679999.
